Ifunanya Nwangene was asleep last Saturday morning in her ground-floor apartment in Nigeria's capital city when she was awoken at around 08:00 by a searing pain on her wrist. Her father, Christopher Nwangene, recounted that a snake came up on her bed and bit her.

Ifunanya, a well-known soprano singer in Nigeria, understood the urgency of obtaining antivenom. Her father revealed that she applied a tourniquet to her arm—a measure once recommended for snakebites but now discouraged due to potential harm.

In dire need of medical assistance, Ifunanya went to Abuja's Federal Medical Centre, only to discover that the hospital lacked the necessary antivenom. Christopher Nwangene immediately contacted his brother for support, as Ifunanya later described feeling unwell.

Despite receiving some antivenom and being placed on a drip, Ifunanya's condition worsened, and she ultimately succumbed to the effects of the snakebite. The incident has not only raised concerns about the healthcare response to snakebites but has also sparked scrutiny over the provision of antivenom in hospitals across Nigeria.

This tragedy underscores the urgent public health crisis, with snakebites causing significant fatalities in Nigeria, where it is estimated that 20,000 incidents occur each year. The health ministry and other agencies are now called upon to improve the availability of effective treatments and ensure accessibility across the country. As calls for change grow louder, the need for a systemic solution to the growing snakebite epidemic in Nigeria becomes increasingly clear.